サマリー

Agomelatineは、構造的にメラトニンと密接な関係がある。Agomelatineはメラトニン受容体の強力なアゴニストであり、セロトニン-2C（5-HT2C）受容体のアンタゴニストであることが、うつ病の動物モデルで検証されている。

市場分析と洞察。世界と日本のAgomelatine市場
本レポートでは、世界と日本のAgomelatine市場に焦点を当てています。
2020年のAgomelatineの世界市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、Agomelatineの市場規模は2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予想されています。

世界のAgomelatineの範囲と市場規模
Agomelatine市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のAgomelatine市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場では、2016年から2027年の期間で、プレイヤー別、タイプ別、アプリケーション別のAgomelatine市場規模に焦点を当てています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
セロトニン受容体2Cアゴニスト
メラトニン受容体2アゴニスト
メラトニン受容体1アゴニスト
セロトニン受容体アゴニスト
セロトニン2C受容体アンタゴニスト

用途別セグメント
うつ病
強迫性障害(Obsessive Compulsive Disorder)
睡眠障害
全般性不安障害
多発性硬化症
全身性外傷性疼痛
自閉症
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
Servier
Rovi Pharma
ノバルティス
ネクティッド社
江蘇省Haosen Pharmaceutical Group

ページTOPに戻る

目次

1 Study Coverage
1.1 Agomelatine Product Introduction
1.2 Market by Type
1.2.1 Global Agomelatine Market Size Growth Rate by Type
1.2.2 Serotonin 2C Agonist
1.2.3 Melatonin Receptor 2 Agonist
1.2.4 Melatonin Receptor 1 Agonist
1.2.5 Serotonin Receptor Agonist
1.2.6 Serotonin 2C Receptor Antagonist
1.3 Market by Application
1.3.1 Global Agomelatine Market Size Growth Rate by Application
1.3.2 Depression
1.3.3 Obsessive Compulsive Disorder
1.3.4 Sleep Disorders
1.3.5 Generalized Anxiety Disorder
1.3.6 Multiple Sclerosis
1.3.7 Systemic Traumatic Pain
1.3.8 Autism
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Agomelatine Market Size, Estimates and Forecasts
2.1.1 Global Agomelatine Revenue 2016-2027
2.1.2 Global Agomelatine Sales 2016-2027
2.2 Global Agomelatine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Agomelatine Historical Market Size by Region (2016-2021)
2.3.1 Global Agomelatine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Agomelatine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Agomelatine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Agomelatine Sales Forecast by Region (2022-2027)
2.4.2 Global Agomelatine Revenue Forecast by Region (2022-2027)

3 Global Agomelatine Competitor Landscape by Players
3.1 Global Top Agomelatine Manufacturers by Sales
3.1.1 Global Agomelatine Sales by Manufacturer (2016-2021)
3.1.2 Global Agomelatine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Agomelatine Manufacturers by Revenue
3.2.1 Key Agomelatine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Agomelatine Revenue by Manufacturers (2016-2021)
3.2.3 Global Agomelatine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Agomelatine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Agomelatine Revenue in 2020
3.2.6 Global Agomelatine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Agomelatine Price by Manufacturers
3.4 Global Agomelatine Manufacturing Base Distribution, Product Types
3.4.1 Agomelatine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Agomelatine Product Type
3.4.3 Date of International Manufacturers Enter into Agomelatine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Agomelatine Market Size by Type (2016-2021)
4.1.1 Global Agomelatine Sales by Type (2016-2021)
4.1.2 Global Agomelatine Revenue by Type (2016-2021)
4.1.3 Agomelatine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Agomelatine Market Size Forecast by Type (2022-2027)
4.2.1 Global Agomelatine Sales Forecast by Type (2022-2027)
4.2.2 Global Agomelatine Revenue Forecast by Type (2022-2027)
4.2.3 Agomelatine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Agomelatine Market Size by Application (2016-2021)
5.1.1 Global Agomelatine Sales by Application (2016-2021)
5.1.2 Global Agomelatine Revenue by Application (2016-2021)
5.1.3 Agomelatine Price by Application (2016-2021)
5.2 Agomelatine Market Size Forecast by Application (2022-2027)
5.2.1 Global Agomelatine Sales Forecast by Application (2022-2027)
5.2.2 Global Agomelatine Revenue Forecast by Application (2022-2027)
5.2.3 Global Agomelatine Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Agomelatine Market Size YoY Growth 2016-2027
6.1.1 Japan Agomelatine Sales YoY Growth 2016-2027
6.1.2 Japan Agomelatine Revenue YoY Growth 2016-2027
6.1.3 Japan Agomelatine Market Share in Global Market 2016-2027
6.2 Japan Agomelatine Market Size by Players (International and Local Players)
6.2.1 Japan Top Agomelatine Players by Sales (2016-2021)
6.2.2 Japan Top Agomelatine Players by Revenue (2016-2021)
6.3 Japan Agomelatine Historic Market Review by Type (2016-2021)
6.3.1 Japan Agomelatine Sales Market Share by Type (2016-2021)
6.3.2 Japan Agomelatine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Agomelatine Price by Type (2016-2021)
6.4 Japan Agomelatine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Agomelatine Sales Forecast by Type (2022-2027)
6.4.2 Japan Agomelatine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Agomelatine Price Forecast by Type (2022-2027)
6.5 Japan Agomelatine Historic Market Review by Application (2016-2021)
6.5.1 Japan Agomelatine Sales Market Share by Application (2016-2021)
6.5.2 Japan Agomelatine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Agomelatine Price by Application (2016-2021)
6.6 Japan Agomelatine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Agomelatine Sales Forecast by Application (2022-2027)
6.6.2 Japan Agomelatine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Agomelatine Price Forecast by Application (2022-2027)

7 North America
7.1 North America Agomelatine Market Size YoY Growth 2016-2027
7.2 North America Agomelatine Market Facts & Figures by Country
7.2.1 North America Agomelatine Sales by Country (2016-2021)
7.2.2 North America Agomelatine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Agomelatine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Agomelatine Market Facts & Figures by Region
8.2.1 Asia Pacific Agomelatine Sales by Region (2016-2021)
8.2.2 Asia Pacific Agomelatine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Agomelatine Market Size YoY Growth 2016-2027
9.2 Europe Agomelatine Market Facts & Figures by Country
9.2.1 Europe Agomelatine Sales by Country (2016-2021)
9.2.2 Europe Agomelatine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Agomelatine Market Size YoY Growth 2016-2027
10.2 Latin America Agomelatine Market Facts & Figures by Country
10.2.1 Latin America Agomelatine Sales by Country (2016-2021)
10.2.2 Latin America Agomelatine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Agomelatine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Agomelatine Market Facts & Figures by Country
11.2.1 Middle East and Africa Agomelatine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Agomelatine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Servier
12.1.1 Servier Corporation Information
12.1.2 Servier Description and Business Overview
12.1.3 Servier Agomelatine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Servier Agomelatine Products Offered
12.1.5 Servier Recent Development
12.2 Rovi Pharma
12.2.1 Rovi Pharma Corporation Information
12.2.2 Rovi Pharma Description and Business Overview
12.2.3 Rovi Pharma Agomelatine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Rovi Pharma Agomelatine Products Offered
12.2.5 Rovi Pharma Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Agomelatine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Agomelatine Products Offered
12.3.5 Novartis Recent Development
12.4 Nectid Inc
12.4.1 Nectid Inc Corporation Information
12.4.2 Nectid Inc Description and Business Overview
12.4.3 Nectid Inc Agomelatine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Nectid Inc Agomelatine Products Offered
12.4.5 Nectid Inc Recent Development
12.5 Jiangsu Haosen Pharmaceutical Group
12.5.1 Jiangsu Haosen Pharmaceutical Group Corporation Information
12.5.2 Jiangsu Haosen Pharmaceutical Group Description and Business Overview
12.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Jiangsu Haosen Pharmaceutical Group Agomelatine Products Offered
12.5.5 Jiangsu Haosen Pharmaceutical Group Recent Development
12.11 Servier
12.11.1 Servier Corporation Information
12.11.2 Servier Description and Business Overview
12.11.3 Servier Agomelatine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Servier Agomelatine Products Offered
12.11.5 Servier Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Agomelatine Industry Trends
13.2 Agomelatine Market Drivers
13.3 Agomelatine Market Challenges
13.4 Agomelatine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Agomelatine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer